Selenium in oxidation state zero is a potent and selective anti-leukemia/lymphoma agent

被引：0
|
作者：
Sieber, F [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
EXPERIMENTAL HEMATOLOGY | 2003年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
178
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [31] A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490
    Caceres-Cortes, Julio R.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (07) : 717 - 722
  • [32] A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms
    Zhang, Peng
    Luo, Wu
    Zhang, Zixin
    Lv, Mingchong
    Sang, Longkang
    Wen, Yuhan
    Wang, Lingxiang
    Ding, Changhao
    Wu, Kun
    Li, Fengjiao
    Nie, Yueqi
    Zhu, Jiaoyue
    Liu, Xiaofeng
    Yi, Yan
    Ding, Xiaofeng
    Zeng, Youlin
    Liu, Zhonghua
    ADVANCED SCIENCE, 2024, 11 (32)
  • [33] Potent anti-leukemia activities of humanized CD19-targeted CAR-T cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, J.
    Wang, G.
    Zheng, J.
    Xu, K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1719 - 1720
  • [34] Identification of the Histone Deacetylase Inhibitor (HDACi), AR-42, as a Novel Anti-Leukemia Stem Cell Agent in Acute Myeloid Leukemia (AML)
    Hassane, Duane
    Balys, Marlene
    Marcucci, Guido
    Byrd, John C.
    Jordan, Craig T.
    Guzman, Monica L.
    BLOOD, 2009, 114 (22) : 817 - 817
  • [35] PENTOSAN POLYSULFATE, A SULFATED OLIGOSACCHARIDE, IS A POTENT AND SELECTIVE ANTI-HIV AGENT INVITRO
    BABA, M
    NAKAJIMA, M
    SCHOLS, D
    PAUWELS, R
    BALZARINI, J
    DECLERCQ, E
    ANTIVIRAL RESEARCH, 1988, 9 (06) : 335 - 343
  • [36] HALOPERIDIDE (R 3201), A HIGHLY POTENT AND SELECTIVE ANTI-EMETIC AGENT IN DOGS
    JANSSEN, PA
    NIEMEGEERS, C, C
    NATURE, 1961, 190 (477) : 911 - &
  • [37] Graphdiyne oxide nanosheets display selective anti-leukemia efficacy against DNMT3A-mutant AML cells
    Qiwei Wang
    Ying Liu
    Hui Wang
    Penglei Jiang
    Wenchang Qian
    Min You
    Yingli Han
    Xin Zeng
    Jinxin Li
    Huan Lu
    Lingli Jiang
    Meng Zhu
    Shilin Li
    Kang Huang
    Mingmin Tang
    Xinlian Wang
    Liang Yan
    Zecheng Xiong
    Xinghua Shi
    Ge Bai
    Huibiao Liu
    Yuliang Li
    Yuliang Zhao
    Chunying Chen
    Pengxu Qian
    Nature Communications, 13
  • [38] Graphdiyne oxide nanosheets display selective anti-leukemia efficacy against DNMT3A-mutant AML cells
    Wang, Qiwei
    Liu, Ying
    Wang, Hui
    Jiang, Penglei
    Qian, Wenchang
    You, Min
    Han, Yingli
    Zeng, Xin
    Li, Jinxin
    Lu, Huan
    Jiang, Lingli
    Zhu, Meng
    Li, Shilin
    Huang, Kang
    Tang, Mingmin
    Wang, Xinlian
    Yan, Liang
    Xiong, Zecheng
    Shi, Xinghua
    Bai, Ge
    Liu, Huibiao
    Li, Yuliang
    Zhao, Yuliang
    Chen, Chunying
    Qian, Pengxu
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [39] Differentiation-Chronology Specific Function of DNMT1 and Selective Anti-Leukemia Stem-Cell Therapy
    Negrotto, Soledad
    Hu, Zhenbo
    Link, Kevin A.
    Duong, Hien
    Schade, Andrew E.
    Maciejewski, Jaroslaw P.
    Mulloy, James C.
    Saunthararajah, Yogenthiran
    BLOOD, 2008, 112 (11) : 81 - 82
  • [40] Human CD56bright NK Cells Acquire Potent Anti-Leukemia Functionality Following IL-15 Priming
    Wagner, Julia A.
    Romee, Rizwan
    Rosario, Maximillian
    Berrien-Elliott, Melissa M.
    Schneider, Stephanie E.
    Leong, Jeffrey W.
    Sullivan, Ryan P.
    Jewell, Brea A.
    Schappe, Timothy
    Abdel-Latif, Sara
    Ireland, Aaron R.
    Jaishankar, Devika
    King, Justin A.
    Vij, Ravi
    Fehniger, Todd A.
    BLOOD, 2016, 128 (22)
12345